AMYLIN Trademark

Trademark Overview

On Tuesday, November 9, 2004, a trademark application was filed for AMYLIN with the United States Patent and Trademark Office. The USPTO has given the AMYLIN trademark a serial number of 78513968. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 23, 2018. This trademark is owned by Amylin Pharmaceuticals, Inc.. The AMYLIN trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, arranging and conducting medical educational conferences, exhibitions, training courses, and seminars in the fields of medicine, pharmaceuticals, and medical science; development and dissemination of educational materials for others in the fields of medicine, pharmaceuticals and medical science
amylin

General Information

Serial Number78513968
Word MarkAMYLIN
Filing DateTuesday, November 9, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 23, 2018
Registration Number3282372
Registration DateTuesday, August 21, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 5, 2007

Trademark Statements

Indication of Colors claimedThe color(s) white, blue and green is/are claimed as a feature of the mark.
Description of the Colors ClaimedThe colors blue and green appear in the side-by-side square design of the mark, with the color green appearing to the left of the color blue. The wording "Amylin" is printed inside the blue square in the color white. The colors are shown in the shades pantone blue and green.
Goods and ServicesEducational services, namely, arranging and conducting medical educational conferences, exhibitions, training courses, and seminars in the fields of medicine, pharmaceuticals, and medical science; development and dissemination of educational materials for others in the fields of medicine, pharmaceuticals and medical science
Section 2(f) Limitation Statementas to "AMYLIN"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 23, 2018
Primary Code041
First Use Anywhere DateSunday, March 20, 2005
First Use In Commerce DateSunday, March 20, 2005

Trademark Owner History

Party NameAMYLIN PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSAN DIEGO, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, March 23, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, August 21, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 17, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, September 17, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 17, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 29, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 22, 2012TEAS SECTION 8 & 15 RECEIVED
Thursday, February 26, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 26, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 13, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 13, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 21, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, June 5, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2007NOTICE OF PUBLICATION
Thursday, April 5, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 5, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 5, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, April 5, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, April 5, 2007EXAMINERS AMENDMENT -WRITTEN
Friday, March 16, 2007AMENDMENT FROM APPLICANT ENTERED
Friday, March 16, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 16, 2007ASSIGNED TO LIE
Thursday, February 8, 2007FAX RECEIVED
Thursday, February 8, 2007UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Thursday, February 8, 2007FAX RECEIVED
Tuesday, November 14, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 8, 2006NON-FINAL ACTION E-MAILED
Tuesday, August 8, 2006NON-FINAL ACTION WRITTEN
Thursday, July 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 10, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 10, 2006NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2006NON-FINAL ACTION WRITTEN
Thursday, December 22, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 13, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 13, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 26, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 22, 2005NON-FINAL ACTION E-MAILED
Wednesday, June 22, 2005NON-FINAL ACTION WRITTEN
Wednesday, June 15, 2005NON-FINAL ACTION E-MAILED
Wednesday, June 15, 2005USE AMENDMENT ACCEPTED
Wednesday, June 15, 2005NON-FINAL ACTION WRITTEN
Wednesday, June 15, 2005ASSIGNED TO EXAMINER
Tuesday, June 14, 2005ASSIGNED TO EXAMINER
Sunday, April 10, 2005AMENDMENT TO USE PROCESSING COMPLETE
Thursday, March 31, 2005USE AMENDMENT FILED
Thursday, March 31, 2005TEAS AMENDMENT OF USE RECEIVED
Monday, November 15, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

amylin medical educational fields medicine science pharmaceuticals development others materials dissemination